Login / Signup

Model-informed drug repurposing: Viral kinetic modelling to prioritize rational drug combinations for COVID-19.

Michael G DoddsRajesh KrishnaAntonio GoncalvesCraig R Rayner
Published in: British journal of clinical pharmacology (2020)
Our work highlights the use of model-informed drug repurposing approaches to better rationalize effective treatments for COVID-19.
Keyphrases
  • sars cov
  • coronavirus disease
  • adverse drug
  • drug induced
  • respiratory syndrome coronavirus